CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813879991
- Phone
- 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-12 | UBS Oncology Impact Fund L.P. 10% owner | Conversion · Series C Convertible Preferred Stock | −649,030 | 0 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion | +1,136,525 | 1,136,525 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion | +3,551,640 | 4,688,165 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion | +2,276,692 | 6,964,857 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion | +649,030 | 7,613,887 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Purchase | +300,000 | $21.00 | $6.3M | 7,913,887 |
| 2021-01-12 | GADICKE ANSBERT Director | Conversion · Series Seed Convertible Preferred Stock | −1,136,525 | 0 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion · Series A Convertible Preferred Stock | −3,551,640 | 0 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion · Series B Convertible Preferred Stock | −2,276,692 | 0 | ||
| 2021-01-12 | GADICKE ANSBERT Director | Conversion · Series C Convertible Preferred Stock | −649,030 | 0 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +1,136,525 | 1,136,525 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +2,912,345 | 2,912,345 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +639,295 | 639,295 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +455,338 | 455,338 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +182,135 | 182,135 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +71,599 | 526,937 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +143,198 | 325,333 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +71,599 | 71,599 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Conversion | +214,798 | 214,798 | ||
| 2021-01-12 | Jovan-Embiricos Morana Director | Purchase | +95,238 | $21.00 | $2.0M | 622,175 |
Page 21 of 23 · 446 trades